Your browser doesn't support javascript.
loading
Response to ruxolitinib in patients with intermediate-1-, intermediate-2-, and high-risk myelofibrosis: results of the UK ROBUST Trial.
Mead, Adam J; Milojkovic, Dragana; Knapper, Steven; Garg, Mamta; Chacko, Joseph; Farquharson, Mira; Yin, John; Ali, Sahra; Clark, Richard E; Andrews, Chris; Dawson, Meryem Ktiouet; Harrison, Claire.
Afiliación
  • Mead AJ; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Milojkovic D; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
  • Knapper S; Department of Haematology, Cardiff University, Heath Park, Cardiff, UK.
  • Garg M; Leicester Royal Infirmary, Leicester, UK.
  • Chacko J; The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth, UK.
  • Farquharson M; Department of Haematology, Western General Hospital, Edinburgh, UK.
  • Yin J; Department of Haematology, Manchester Royal Infirmary, Manchester, UK.
  • Ali S; Hull and East Yorkshire Hospitals NHS Trust, Hull, UK.
  • Clark RE; Department of Haematology, Royal Liverpool University Hospital, Liverpool, UK.
  • Andrews C; Novartis Pharmaceuticals UK, Frimley, UK.
  • Dawson MK; Novartis Pharmaceuticals UK, Frimley, UK.
  • Harrison C; Guy's and St. Thomas' NHS Foundation Trust, London, UK.
Br J Haematol ; 170(1): 29-39, 2015 Jul.
Article en En | MEDLINE | ID: mdl-25824940

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Mielofibrosis Primaria Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Br J Haematol Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Mielofibrosis Primaria Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Br J Haematol Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido